Drawing for BR

USPTO serial 87540379

BR

Reviewed by CopyMark Law Group

Reg. 5854175Status 710
Filing date
Status date
Registration date
Sep 10, 2019
Examiner
PERRY, KIMBERLY B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel I. Schloss

DANIEL I. SCHLOSS GREENBERG TRAURIG, LLP200 PARK AVE 38TH FLNEW YORK, NY 10166UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for hypertension prevention; Pharmaceutical preparations acting on nervous system; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organs; allergy medications; pharmaceutical preparations for the treatment of cardiovascular system related diseases and disorders; pharmaceutical preparations for treating respiratory organs diseases; pharmaceutical preparations acting on digestive organs for treating digestive diseases; pharmaceutical preparations for urogenital organs for treating urogenital diseases; vitamin preparations; pharmaceutical preparations for endocrine systems for the treatment of endocrine-related diseases and disorders; pharmaceutical preparations for tumor treatment; antibiotic preparations for medical purposes; biological preparations for medical purposes for the treatment of diseases and disorders of the sensory organs, cardiovascular system, digestive organs, urogenital organs, and endocrine system, and for the treatment of allergies and tumors; antifungal preparations for medical purposes; pharmaceutical preparations for cell therapy; Pharmaceutical preparations for the treatment of leukemia; Nutraceuticals for use as dietary supplementsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 20, 2026C8..CANCELLED SEC. 8 (6-YR)—
Sep 10, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 25, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 25, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 5, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 22, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 14, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
May 10, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 8, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 8, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 8, 2019CNSISUSPENSION INQUIRY WRITTEN—
Dec 6, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 15, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 15, 2018GNSLLETTER OF SUSPENSION E-MAILED—
May 15, 2018CNSLSUSPENSION LETTER WRITTEN—
May 15, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 11, 2018ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
May 7, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 19, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2017DOCKASSIGNED TO EXAMINER—
Sep 2, 2017AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 27, 2017ALIEASSIGNED TO LIE—
Aug 8, 2017PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 1, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 29, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 27, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance